In January of 2013, the Federal Food and Drug Administration (FDA) issued a safety communication advising healthcare professionals and the general public regarding the risks associated with metal-on-metal hip implants. These medical devices have been linked to serious adverse results, including loosening of the joint, pain, bone and soft tissue damage, as well as metal poisoning. Because of the strict time limitations involved in hip implant lawsuit cases, anyone who believes they may ...
First Federal DePuy Hip Replacement Trial Set to Begin
Posted September 10, 2013 in Depuy Hip Replacements | Drug and Medical Device Lawsuits | Product News and Recalls
The National Law Journal is reporting that the first federal trial involving DePuy Orthopaedic Inc.’s metal-on-metal hip implant devices is set to begin on September 9, 2013 in Cleveland, Ohio. This is the first of nearly 8,000 cases currently being coordinated in a multidistrict litigation (MDL) before Judge David Katz.
This first case involves a woman who claims she had to remove her DePuy ASR XL hip implant after her hip dislocated. In general, Plaintiffs are alleging that ...
continue reading...Nearly 16,800 recorded problems with metal hip joints
Posted September 27, 2012 in Depuy Hip Replacements | Drug and Medical Device Lawsuits | Product News and Recalls
According to a Bloomberg story, nearly 16,800 adverse events associated with metal-on-metal hip implants were reported in the United States from 2000 through 2011.
Metal-on-metal hip implants, which have both a ball and socket coated in an alloy made of cobalt and chromium, were originally introduced as an ostensibly more durable alternative to earlier plastic and ceramic models. But a number ...
continue reading...
